Auster Martin's Form 4 filing
Ventyx Biosciences, Inc. (VTYX) · filed Dec 6, 2022
- Accession no.
- 0000899243-22-037793
- Filed
- Dec 6, 2022
- Trade date
- Dec 2, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.83M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Auster MartinCIK 0001875786 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2022 | Common Stock | MOption exerciseAcquired | +50,000 | $3.45 | +$172,500 | 145,296 | Direct | |
| Dec 2, 2022 | Common Stock | SSaleDisposed | −97,647 | $29.01F1 | −$2,832,739.47 | 47,649 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2022 | Common Stock | MOption exerciseDisposed | −50,000 | $0.00 | $0 | 331,184 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents the weighted average share price of an aggregate total of 97,647 shares sold in the price range of $28.98 to $29.15. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.